%0 English Abstract
%T [Uterine leiomyosarcoma - French guidelines from the GSF/NETSARC and TMRG groups].
%A Collineau B
%A Genestie C
%A Croce S
%A Meeus P
%A Floquet A
%A Guyon F
%A Llacer-Moscardo C
%A Lebreton C
%A Taieb S
%A Toulmonde M
%A Blay JY
%A Bonvalot S
%A Ray-Coquard I
%A Pautier P
%A Duffaud F
%J Bull Cancer
%V 0
%N 0
%D Feb 2023 28
%M 36863922
%F 1.318
%R 10.1016/j.bulcan.2023.01.009
%X Uterine leiomyosarcomas represent the most common uterine sarcomas. The prognosis is poor with metastatic recurrence in more than half of the cases. The purpose of this review is to make French recommendations for the management of uterine leiomyosarcomas within the framework of the French Sarcoma Group - Bone Tumor Study Group (GSF-GETO)/NETSARC+ and Malignant Rare Gynecological Tumors (TMRG) networks in order to optimize their therapeutic management. The initial assessment includes a MRI with diffusion perfusion sequence. The diagnosis is histological with a review in an expert center (Reference Network in Sarcoma Pathology (RRePS)). Total hysterectomy with bilateral salpingectomy, en bloc without morcellation, is performed when complete resection is possible, whatever the stage. There is no indication of systematic lymph node dissection. Bilateral oophorectomy is indicated in peri-menopausal or menopausal women. Adjuvant external radiotherapy is not a standard. Adjuvant chemotherapy is not a standard. It can be an option and consists in doxorobucin based protocols. In the event of local recurrence, the therapeutic options are based on revision surgery and/or radiotherapy. Systemic treatment with chemotherapy is most often indicated. In case of metastatic disease, surgical treatment remains indicated when resecable. In cases of oligo-metastatic disease, focal treatment of metastases should be considered. In the case of stage IV, chemotherapy is indicated, and is based on first-line doxorubicin-based protocols. In the event of excessive deterioration in general condition, management by exclusive supportive care is recommended. External palliative radiotherapy can be proposed for symptomatic purposes.